Recombinant Human Calcium binding protein P22 is a Human Full Length protein, in the 1 to 195 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.
M G S S H H H H H H S S G L V P R G S H M M G S R A S T L L R D E E L E E I K K E T G F S H S Q I T R L Y S R F T S L D K G E N G T L S R E D F Q R I P E L A I N P L G D R I I N A F F P E G E D Q V N F R G F M R T L A H F R P I E D N E K S K D V N G P E P L N S R S N K L H F A F R L Y D L D K D E K I S R D E L L Q V L R M M V G V N I S D E Q L G S I A D R T I Q E A D Q D G D S A I S F T E F V K V L E K V D V E Q K M S I R F L H
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application MS | Reactivity Reacts | Dilution info - | Notes - |
Calcium-binding protein involved in different processes such as regulation of vesicular trafficking, plasma membrane Na(+)/H(+) exchanger and gene transcription. Involved in the constitutive exocytic membrane traffic. Mediates the association between microtubules and membrane-bound organelles of the endoplasmic reticulum and Golgi apparatus and is also required for the targeting and fusion of transcytotic vesicles (TCV) with the plasma membrane. Functions as an integral cofactor in cell pH regulation by controlling plasma membrane-type Na(+)/H(+) exchange activity. Affects the pH sensitivity of SLC9A1/NHE1 by increasing its sensitivity at acidic pH. Required for the stabilization and localization of SLC9A1/NHE1 at the plasma membrane. Inhibits serum- and GTPase-stimulated Na(+)/H(+) exchange. Plays a role as an inhibitor of ribosomal RNA transcription by repressing the nucleolar UBF1 transcriptional activity. May sequester UBF1 in the nucleoplasm and limit its translocation to the nucleolus. Associates to the ribosomal gene promoter. Acts as a negative regulator of the calcineurin/NFAT signaling pathway. Inhibits NFAT nuclear translocation and transcriptional activity by suppressing the calcium-dependent calcineurin phosphatase activity. Also negatively regulates the kinase activity of the apoptosis-induced kinase STK17B. Inhibits both STK17B auto- and substrate-phosphorylations in a calcium-dependent manner.
CHP, CHP1, Calcineurin B homologous protein 1, Calcineurin B-like protein, Calcium-binding protein CHP, Calcium-binding protein p22, EF-hand calcium-binding domain-containing protein p22
Recombinant Human Calcium binding protein P22 is a Human Full Length protein, in the 1 to 195 aa range, expressed in Escherichia coli, with >95% purity and suitable for SDS-PAGE, MS.
pH: 7.5
Constituents: 10% Glycerol (glycerin, glycerine), 0.316% Tris HCl
ab99141 was purified by using conventional chromatography.
Calcium-binding protein involved in different processes such as regulation of vesicular trafficking, plasma membrane Na(+)/H(+) exchanger and gene transcription. Involved in the constitutive exocytic membrane traffic. Mediates the association between microtubules and membrane-bound organelles of the endoplasmic reticulum and Golgi apparatus and is also required for the targeting and fusion of transcytotic vesicles (TCV) with the plasma membrane. Functions as an integral cofactor in cell pH regulation by controlling plasma membrane-type Na(+)/H(+) exchange activity. Affects the pH sensitivity of SLC9A1/NHE1 by increasing its sensitivity at acidic pH. Required for the stabilization and localization of SLC9A1/NHE1 at the plasma membrane. Inhibits serum- and GTPase-stimulated Na(+)/H(+) exchange. Plays a role as an inhibitor of ribosomal RNA transcription by repressing the nucleolar UBF1 transcriptional activity. May sequester UBF1 in the nucleoplasm and limit its translocation to the nucleolus. Associates to the ribosomal gene promoter. Acts as a negative regulator of the calcineurin/NFAT signaling pathway. Inhibits NFAT nuclear translocation and transcriptional activity by suppressing the calcium-dependent calcineurin phosphatase activity. Also negatively regulates the kinase activity of the apoptosis-induced kinase STK17B. Inhibits both STK17B auto- and substrate-phosphorylations in a calcium-dependent manner.
Belongs to the calcineurin regulatory subunit family. CHP subfamily.
Phosphorylated; decreased phosphorylation is associated with an increase in SLC9A1/NHE1 Na(+)/H(+) exchange activity. Phosphorylation occurs in serum-dependent manner. The phosphorylation state may regulate the binding to SLC9A1/NHE1.
Calcium binding protein P22 also known as CABP22 plays a role in calcium signaling by interacting with calcium ions. This protein has a molecular mass of around 22 kDa reflecting its name. Expression of CABP22 occurs in various tissues but predominantly in the brain which suggests its importance in neural activities. Scientists study this protein to understand how neurons respond to calcium fluctuations and consequently how they communicate in the nervous system.
CABP22 modulates intracellular calcium levels and is not known to be part of a complex. It influences calcium-dependent tasks such as neurotransmitter release gene expression and protein phosphorylation affecting cellular behavior. Its function is critical in fine-tuning the activity of neurons and maintaining proper neuronal signaling and plasticity.
CABP22 functions within the calcium signaling and synaptic transmission pathways. It influences the activities of related proteins such as calmodulin and troponin which are essential in transducing calcium signals to trigger specific cellular responses. This connection ensures that CABP22 can regulate calcium dynamics in the cellular environment affecting synaptic strength and plasticity.
CABP22 may relate to neurodegenerative diseases such as Alzheimer's disease where calcium homeostasis fails. It associates with proteins like beta-amyloid which accumulates in Alzheimer's suggesting a link between disrupted calcium signaling and disease progression. CABP22 also could connect to epilepsy as imbalances in calcium could lead to aberrant neuronal firing linking to proteins such as ion channels involved in neuronal excitability.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
15% SDS-PAGE analysis of 3μg ab99141.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com